Kaleido Biosciences, Inc. (KLDO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 5, 2026, 2:29 PM EST
Kaleido Biosciences Revenue
In the year 2021, Kaleido Biosciences had annual revenue of $1.10M with 13.23% growth. Kaleido Biosciences had revenue of $492.00K in the quarter ending December 31, 2021, with 102.47% growth.
Revenue
1.10M
Revenue Growth
+13.23%
P/S Ratio
0.00
Revenue / Employee
14.53K
Employees
76
Market Cap
4.26K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 1.10M | 129.00K | 13.23% |
| Dec 31, 2020 | 975.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ONE Bio | 53.91M |
| Synovics Pharmaceuticals | 19.09M |
| Hemagen Diagnostics | 4.04M |
| MultiCell Technologies | 805.24K |
| Syros Pharmaceuticals | 386.00K |
| MetaStat | 23.30K |